The primary in vitro anticancer activity of 'half-mustard type' phenothiazines in NCI's revised anticancer screening paradigm

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 337-348

  Wuonola, Mark A ^a   Palfreyman, Michael G ^a   Motohashi, Noboru ^b   Kawase, Masami ^c   Gabay, Sabit ^d   Gupta, Radha Raman ^e   Molńar, Joseph ^f  

^a Scriptgen Pharmaceuticals Inc   (United States)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c JOSAI UNIVERSITY   (Japan)

^d Intl Bio Medical Advisory Group   (United States)

^e UNIVERSITY OF RAJASTHAN   (India)

^f UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Anticancer activity; Phenothiazines

Indexed keywords

BUTANEDIOL; NITROGEN; PHENOTHIAZINE DERIVATIVE; PROPYLENE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; GROWTH INHIBITION; HUMAN; HUMAN CELL; KIDNEY CANCER; LEUKEMIA CELL; LUNG NON SMALL CELL CANCER; MELANOMA CELL; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; GROWTH INHIBITORS; HUMANS; PHENOTHIAZINES; TUMOR CELLS, CULTURED;

EID: 0031922586     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. (a) Gottlieb LS, Hazel M, Broitman SA and Zamcheck N: Effect of chlorpromazine on a transplantable mouse mastocytoma. Proc Fed Proc 19: 181, 1960.
2. (b) Gottlieb LS, Broitman SA, Vitale JJ and Zamcheck N: Influence of alcohol and dietary magnesium upon hypercholesterolemia and atherogenesis in the rat. J Lab Clin Med 53: 433-441, 1959.
3. (c) Gottlieb LS, Broitman SA, Vitale JJ and Zamcheck N: Failure of endogeneous serotonin to produce lesions of the carcinoid syndrome. A M A Arch Pathol 69: 77-81, 1960.
4. (d) Molnár J, Mándi Y, Boda K and Földeák S: The effect of ring-substituted and quaternary chlorpromazine derivatives on the survival of the NK/Ly ascites tumor bearing mice. Neoplasma 29: 215-222, 1982.
5. Shenoy MA and Singh BB: Cytotoxic and radiosensitizing effects of chlorpromazine hydrochloride in sarcoma 180A. Indian J Exp Biol 18: 791-795, 1980.
6. Motohashi N: Phenothiazines and calmodulin. Anticancer Res 11: 1125-1164, 1991.
7. George KC and Singh BB: Synergism of chlorpromazine and hyperthermia in two mouse solid tumours. Brit J Cancer 45: 309-313, 1982.
8. Motohashi N: Test for antitumor activities of phenothiazines and benzo[a]phenothiazines. (in Japanese) Yakugaku Zasshi 103: 364-371, 1983.
9. Motohashi N: Antitumor activities of phenothiazines (Phenothiazine Oncology). In: Gupta RR (ed.), Phenothiazines and 1,4-benzothiazines. Chemical and biological aspects. Bioactive Molecules. Vol. 4, Elsevier, 1988, pp 705-770.
10. Motohashi N, Gollapudi SR, Emrani J and Bhattiprolu KR: Antitumor properties of phenothiazines. Cancer Invest 9: 305-319, 1991.
11. (a) Cohen MH: Enhancement of the antitumor effect of 1,3-bis(chloroethyl)-1-nitrosourea by chlorpromazine and caffeine. J Natl Cancer Inst 51: 1323-1325, 1973;
12. (b) Cohen MH: Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by various psychotropic drugs in combination with caffeine. J Pharmacol Exp Ther 194: 475-479, 1975.
13. (c) Sobels FH and Mendelson D: Caffeine treatment of the maternal repair system and repair of chromosome breaks induced in Drosophila spermatids. Mutation Res 28: 133-136, 1975.
14. (d) Mendelson D: The effect of caffeine on repair systems in oocytes of Drosophila melanogaster. Mutation Res 22: 145-156, 1974.
15. (e) Mendelson D and Sobels FH: The inhibiting effect of caffeine on the maternal repair of radiation-induced chromosome breaks in Drosophila. Mutation Res 26: 123-128, 1974.
16. (f) Kobayashi T, Yasuda M, Iijima K, Toriizuka K, Cyong J-C and Nagasawa H: Effects of coffee cherry on the immune system in SHN mice. Anticancer Res 16: 1827-1830, 1996.
17. (g) Hibasami H, Achiwa Y, Fujikawa T and Komiya T: Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds. Anticancer Res 16: 1943-1946, 1996.
18. Motohashi N, Kawase M, Kurihara T, Hevér A, Nagy S, Tanaka M and Molnár J: Synthesis and antitumor activity of 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazin-10-yl)alkylureas as potential anticancer agents. Anticancer Res 16: 2525-2532, 1996.
19. Wuonola MA, Palfreyman MG, Motohashi N, Kawase M, Gabay S, Nacsa J and Molnár J: The primary in vitro antitumor screening of "half-mustard type" phenothiazines. Anticancer Res 17: in press, 1997.
20. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE and Paul KD: An information-intensive approach to the molecular pharmacology of cancer. Science 275. 343-349, 1997.